滬深股市續跌1.6%-1.8% 港股午後曾跌逾百點 創科、東方海外及翰森升逾4%-5%
人民幣兌美元中間價今天繼續下調261點子,報7.2056,創逾七個月低。上證四連跌,午後沽盤重現,最低見3,145,現報3,146,續跌1.6%;深成續吐1.8%報10,847。
港股五連跌,恆指繼半日收反覆續跌0.1%後,下午沽壓重現,曾跌逾百點,現報18,817,續跌72點或0.4%,總成交額593億元。
藍籌股榮辱互見,獲招銀國際首予「買入」評級看23.2元的潤電(00836.HK)重越10天線,最高見17.54元,現報17.28元,回升5.9%。
波羅的海乾散貨指數上周五漲2%收1,240四連升,本港相關航運股全線升逾1%-4%,藍籌東方海外(00316.HK)彈力最強,股價反覆高見103.7元,現報102.8元,回升4.2%。
醫藥相關股全線反覆向好,尤其是翰森製藥(03692.HK)扭四連跌,股價午後升幅擴至5.2%報12.86元。藥明生物(02269.HK)、阿里健康(00241.HK)、中生(01177.HK)及石藥(01093.HK)也反覆升逾1%-2%。
上周五繼續回購250萬股的小米(01810.HK)據報投資通訊芯片公司,該股由逾半年低位曾彈逾6%高見10.6元,現報10.42元,回升4.3%。
出口股創科(00669.HK)回升4.1%報84.45元,股價重越10天線(81.9元);但申洲(02313.HK)回吐2%報72.55元。
中芯(00981.HK)、聯通(00762.HK)、貼金價走弱紫金(02899.HK)、中電(00002.HK)、李寧(02331.HK)、安踏(02020.HK)、金沙(01928.HK)、銀娛(00027.HK)、攜程(09961.HK)、京東(09618.HK)、龍湖(00960.HK)及九倉置業(01997.HK)跌逾1.5%-2.5%。
金融股以恆生(00011.HK)及國壽(02628.HK)表現較差,股價報110.6元及12.76元,續跌1.2%及1.5%,後者五連跌。然而,建行(00939.HK)反覆逆彈0.6%報5.03元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.